Robert Huryk

966 total citations
18 papers, 806 citations indexed

About

Robert Huryk is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert Huryk has authored 18 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert Huryk's work include Beetle Biology and Toxicology Studies (3 papers), Kidney Stones and Urolithiasis Treatments (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Robert Huryk is often cited by papers focused on Beetle Biology and Toxicology Studies (3 papers), Kidney Stones and Urolithiasis Treatments (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Robert Huryk collaborates with scholars based in United States. Robert Huryk's co-authors include William R. Fair, Warren D.W. Heston, Paul Russo, Carolyn Mies, C. Thomas Powell, Neil Fleshner, Sai L. Su, Erick Edwards, Ron Israeli and Gilbert J. Wise and has published in prestigious journals such as The Journal of Urology, Organic Letters and Tetrahedron Letters.

In The Last Decade

Robert Huryk

18 papers receiving 771 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Huryk United States 14 348 313 164 100 74 18 806
James D. Calore United States 16 381 1.1× 232 0.7× 162 1.0× 106 1.1× 27 0.4× 28 936
Timothy Hollister United States 6 473 1.4× 489 1.6× 116 0.7× 107 1.1× 87 1.2× 10 1.4k
Marcelle Guichard France 14 147 0.4× 193 0.6× 259 1.6× 92 0.9× 222 3.0× 26 722
Megumi Baba Japan 19 197 0.6× 395 1.3× 224 1.4× 294 2.9× 31 0.4× 48 977
Jinzhi Wang China 17 119 0.3× 395 1.3× 129 0.8× 129 1.3× 48 0.6× 49 768
Darcy Franicola United States 18 230 0.7× 460 1.5× 145 0.9× 116 1.2× 414 5.6× 65 895
Mark W.C. Hatton Canada 15 107 0.3× 363 1.2× 56 0.3× 57 0.6× 69 0.9× 46 850
Maria Świątkowska Poland 17 130 0.4× 313 1.0× 118 0.7× 54 0.5× 40 0.5× 38 841
Yasuko Nishizawa Japan 19 201 0.6× 444 1.4× 189 1.2× 233 2.3× 123 1.7× 53 1.1k
Rhonda J. Staversky United States 19 437 1.3× 628 2.0× 190 1.2× 171 1.7× 23 0.3× 30 1.1k

Countries citing papers authored by Robert Huryk

Since Specialization
Citations

This map shows the geographic impact of Robert Huryk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Huryk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Huryk more than expected).

Fields of papers citing papers by Robert Huryk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Huryk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Huryk. The network helps show where Robert Huryk may publish in the future.

Co-authorship network of co-authors of Robert Huryk

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Huryk. A scholar is included among the top collaborators of Robert Huryk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Huryk. Robert Huryk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Huang, Xianhai, Ning Shao, Robert Huryk, et al.. (2009). The Discovery of Potent Antitumor Agent C11-Deoxypsymberin/irciniastatin A: Total Synthesis and Biology of Advanced Psymberin Analogs. Organic Letters. 11(4). 867–870. 33 indexed citations
2.
Shao, Ning, Xianhai Huang, Anandan Palani, et al.. (2009). New Applications of PhI(OAc)2 in Synthesis: Total Synthesis and SAR Development of Potent Antitumor Natural Product Psymberin/Irciniastatin A. Synthesis. 2009(17). 2855–2872. 21 indexed citations
3.
Huang, Xianhai, Ning Shao, Anandan Palani, et al.. (2008). Synthesis of seco-psymberin/irciniastatin A: the discovery of a novel PhI(OAc)2 mediated cascade cyclization reaction. Tetrahedron Letters. 49(22). 3592–3595. 15 indexed citations
4.
Balaji, K.C., Robert Huryk, S J Verhulst, & William R. Fair. (2001). Growth of heterotopic LNCaP prostate cancer tumor in nude mice is not affected by dietary calcium. The Prostate. 48(4). 265–273. 5 indexed citations
5.
Pinto, John T., Jie Xing, Brian Suffoletto, et al.. (2000). Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine. The Prostate. 45(4). 304–314. 39 indexed citations
6.
Fleshner, Neil, William R. Fair, Robert Huryk, & Warren D.W. Heston. (1999). VITAMIN E INHIBITS THE HIGH-FAT DIET PROMOTED GROWTH OF ESTABLISHED HUMAN PROSTATE LNCaP TUMORS IN NUDE MICE. The Journal of Urology. 1651–1654. 9 indexed citations
7.
Garzotto, Mark, Adriana Haimovitz‐Friedman, Wen‐Chieh Liao, et al.. (1999). Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase.. PubMed. 59(20). 5194–201. 75 indexed citations
8.
Fleshner, Neil, William R. Fair, Robert Huryk, & Warren D.W. Heston. (1999). VITAMIN E INHIBITS THE HIGH-FAT DIET PROMOTED GROWTH OF ESTABLISHED HUMAN PROSTATE LNCaP TUMORS IN NUDE MICE. The Journal of Urology. 161(5). 1651–1654. 79 indexed citations
9.
Garzotto, Mark, Robert Huryk, William R. Fair, & W. D. W. Heston. (1997). Prostatic tumor implantation in the nude mouse via a perineal approach. The Prostate. 33(1). 60–63. 3 indexed citations
10.
Powell, C. Thomas, et al.. (1996). Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells.. PubMed. 56(18). 4137–41. 33 indexed citations
12.
Israeli, Ron, Wilson H. Miller, Sai L. Su, et al.. (1994). Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.. PubMed. 54(24). 6306–10. 203 indexed citations
13.
Laudone, Vincent P., Thomas R. Morgan, Robert Huryk, Warren D.W. Heston, & William R. Fair. (1989). Cytotoxicity of High Energy Shock Waves: Methodologic Considerations. The Journal of Urology. 141(4). 965–968. 40 indexed citations
14.
Herr, Harry W., Jeffry L. Huffman, Robert Huryk, et al.. (1988). Anticarcinoma activity of rhodamine 123 against a murine renal adenocarcinoma.. PubMed. 48(8). 2061–3. 20 indexed citations
15.
Russo, Paul, Carolyn Mies, Robert Huryk, Warren D.W. Heston, & William R. Fair. (1987). Histopathologic and Ultrastructural Correlates of Tumor Growth Suppression by High Energy Shock Waves. The Journal of Urology. 137(2). 338–341. 69 indexed citations
16.
Russo, Paul, Giovanni Liguori, Warren D.W. Heston, et al.. (1987). Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.. PubMed. 47(22). 5967–70. 23 indexed citations
17.
Yang, Chi‐Rei, et al.. (1987). The Effect of High Energy Shock Waves on Chinese Hamster Ovary Cell. The Journal of Urology. 137(6). 8 indexed citations
18.
Russo, Paul, Robert A. Stephenson, Carolyn Mies, et al.. (1986). High Energy Shock Waves Suppress Tumor Growth in Vitro and in Vivo. The Journal of Urology. 135(3). 626–628. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026